critical safety baseline Inflammatory markers: hsCRP, optional adiponectin, leptin TSH and free T4: Rules out thyroid dysfunction
Regular reassessment with healthcare providers helps determine the ongoing need for treatment, with consideration of factors such as treatment response, side effects, and changes in health status or treatment goals
[DOI] [PubMed] [Google Scholar] Devigny C, Perez-Balderas F, Hoogeland B, Cuboni S, Wachtel R, Mauch CP, et al
Numerous studies, including phase-2b and phase-3 trials, have tested the effectiveness of PT-141 on women suffering from HSDD and female sexual arousal disorder (FSAD)
Q8: What supplies are needed for a KLOW protocol